146 related articles for article (PubMed ID: 21074434)
1. Design, synthesis, and structure-activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists.
Moir EM; Yoshiizumi K; Cairns J; Cowley P; Ferguson M; Jeremiah F; Kiyoi T; Morphy R; Tierney J; Wishart G; York M; Baker J; Cottney JE; Houghton AK; McPhail P; Osprey A; Walker G; Adam JM
Bioorg Med Chem Lett; 2010 Dec; 20(24):7327-30. PubMed ID: 21074434
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and structure-activity relationship study of conformationally constrained analogs of indole-3-carboxamides as novel CB1 cannabinoid receptor agonists.
Kiyoi T; York M; Francis S; Edwards D; Walker G; Houghton AK; Cottney JE; Baker J; Adam JM
Bioorg Med Chem Lett; 2010 Aug; 20(16):4918-21. PubMed ID: 20634067
[TBL] [Abstract][Full Text] [Related]
3. Indole-2-carboxamides as allosteric modulators of the cannabinoid CB₁ receptor.
Piscitelli F; Ligresti A; La Regina G; Coluccia A; Morera L; Allarà M; Novellino E; Di Marzo V; Silvestri R
J Med Chem; 2012 Jun; 55(11):5627-31. PubMed ID: 22571451
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-activity relationships of indole-3-heterocycles as agonists of the CB1 receptor.
Morrison AJ; Adam JM; Baker JA; Campbell RA; Clark JK; Cottney JE; Deehan M; Easson AM; Fields R; Francis S; Jeremiah F; Keddie N; Kiyoi T; McArthur DR; Meyer K; Ratcliffe PD; Schulz J; Wishart G; Yoshiizumi K
Bioorg Med Chem Lett; 2011 Jan; 21(1):506-9. PubMed ID: 21075630
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators.
Nguyen T; German N; Decker AM; Li JX; Wiley JL; Thomas BF; Kenakin TP; Zhang Y
Bioorg Med Chem; 2015 May; 23(9):2195-2203. PubMed ID: 25797163
[TBL] [Abstract][Full Text] [Related]
6. (4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)(cyclohexyl)methanone hydrochloride (LDK1229): a new cannabinoid CB1 receptor inverse agonist from the class of benzhydryl piperazine analogs.
Mahmoud MM; Olszewska T; Liu H; Shore DM; Hurst DP; Reggio PH; Lu D; Kendall DA
Mol Pharmacol; 2015 Feb; 87(2):197-206. PubMed ID: 25411367
[TBL] [Abstract][Full Text] [Related]
7. Piperazine analogs of naphthyridine-3-carboxamides and indole-2-carboxamides: novel 5-HT3 receptor antagonists with antidepressant-like activity.
Dhar AK; Mahesh R; Jindal A; Bhatt S
Arch Pharm (Weinheim); 2015 Jan; 348(1):34-45. PubMed ID: 25581677
[TBL] [Abstract][Full Text] [Related]
8. The discovery of novel indole-2-carboxamides as cannabinoid CB(1) receptor antagonists.
Cowley PM; Baker J; Barn DR; Buchanan KI; Carlyle I; Clark JK; Clarkson TR; Deehan M; Edwards D; Goodwin RR; Jaap D; Kiyoi Y; Mort C; Palin R; Prosser A; Walker G; Ward N; Wishart G; Young T
Bioorg Med Chem Lett; 2011 Jan; 21(1):497-501. PubMed ID: 21075628
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.
Song KS; Lee SH; Chun HJ; Kim JY; Jung ME; Ahn K; Kim SU; Kim J; Lee J
Bioorg Med Chem; 2008 Apr; 16(7):4035-51. PubMed ID: 18243711
[TBL] [Abstract][Full Text] [Related]
10. Dialkylaminoalkyl derivatives of bicyclic compounds with antiplasmodial activity.
Faist J; Seebacher W; Kaiser M; Brun R; Saf R; Weis R
Bioorg Med Chem; 2010 Sep; 18(18):6796-804. PubMed ID: 20709557
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and structure-activity relationships of (indo-3-yl) heterocyclic derivatives as agonists of the CB1 receptor. Discovery of a clinical candidate.
Ratcliffe P; Adam JM; Baker J; Bursi R; Campbell R; Clark JK; Cottney JE; Deehan M; Easson AM; Ecker D; Edwards D; Epemolu O; Evans L; Fields R; Francis S; Harradine P; Jeremiah F; Kiyoi T; McArthur D; Morrison A; Passier P; Pick J; Schnabel PG; Schulz J; Steinbrede H; Walker G; Westwood P; Wishart G; Udo de Haes J
Bioorg Med Chem Lett; 2011 Apr; 21(8):2541-6. PubMed ID: 21411321
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor.
Moloney GP; Angus JA; Robertson AD; Stoermer MJ; Robinson M; Wright CE; McRae K; Christopoulos A
Eur J Med Chem; 2008 Mar; 43(3):513-39. PubMed ID: 17582659
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship study of indole-2-carboxamides identifies a potent allosteric modulator for the cannabinoid receptor 1 (CB1).
Mahmoud MM; Ali HI; Ahn KH; Damaraju A; Samala S; Pulipati VK; Kolluru S; Kendall DA; Lu D
J Med Chem; 2013 Oct; 56(20):7965-75. PubMed ID: 24053617
[TBL] [Abstract][Full Text] [Related]
14. Chemoenzymatic synthesis and cannabinoid activity of a new diazabicyclic amide of phenylacetylricinoleic acid.
López-Ortíz M; Herrera-Solís A; Luviano-Jardón A; Reyes-Prieto N; Castillo I; Monsalvo I; Demare P; Méndez-Díaz M; Regla I; Prospéro-García O
Bioorg Med Chem Lett; 2010 Jun; 20(11):3231-4. PubMed ID: 20457524
[TBL] [Abstract][Full Text] [Related]
15. Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.
Yu M; Lizarzaburu M; Beckmann H; Connors R; Dai K; Haller K; Li C; Liang L; Lindstrom M; Ma J; Motani A; Wanska M; Zhang A; Li L; Medina JC
Bioorg Med Chem Lett; 2010 Mar; 20(5):1758-62. PubMed ID: 20137933
[TBL] [Abstract][Full Text] [Related]
16. 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles.
Huffman JW; Szklennik PV; Almond A; Bushell K; Selley DE; He H; Cassidy MP; Wiley JL; Martin BR
Bioorg Med Chem Lett; 2005 Sep; 15(18):4110-3. PubMed ID: 16005223
[TBL] [Abstract][Full Text] [Related]
17. Identification and hit-to-lead optimization of a novel class of CB1 antagonists.
Letourneau JJ; Jokiel P; Olson J; Riviello CM; Ho KK; McAleer L; Yang J; Swanson RN; Baker J; Cowley P; Edwards D; Ward N; Ohlmeyer MH; Webb ML
Bioorg Med Chem Lett; 2010 Sep; 20(18):5449-53. PubMed ID: 20719511
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and structure-activity relationship of novel opioid κ receptor selective agonists: α-iminoamide derivatives with an azabicyclo[2.2.2]octene skeleton.
Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Iwai T; Gouda H; Hirono S; Nagasea H
Bioorg Med Chem Lett; 2014 Nov; 24(21):4980-3. PubMed ID: 25283554
[TBL] [Abstract][Full Text] [Related]
19. Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor: in vitro and in vivo activity.
Acker BA; Jacobsen EJ; Rogers BN; Wishka DG; Reitz SC; Piotrowski DW; Myers JK; Wolfe ML; Groppi VE; Thornburgh BA; Tinholt PM; Walters RR; Olson BA; Fitzgerald L; Staton BA; Raub TJ; Krause M; Li KS; Hoffmann WE; Hajos M; Hurst RS; Walker DP
Bioorg Med Chem Lett; 2008 Jun; 18(12):3611-5. PubMed ID: 18490160
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor.
Qiao CJ; Ali HI; Ahn KH; Kolluru S; Kendall DA; Lu D
Eur J Med Chem; 2016 Oct; 121():517-529. PubMed ID: 27318976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
